I feel like the company was throwing darts at the beginning of covid when picking primary and secondary endpoints. Also we would let anyone in the trials with no restrictions(no company does that with such a low sample size) Now we know, who benefits the most and which endpoints to focus. This trial is not like the trials of the past. We have a larger sample size and prior knowledge. I’m excited to see it kick off, but more excited to hear it ended with the results we all expect. But that’s just me. I guess I have been corrupted by Goosebumps and Shellys positivity. But management better get this trial started and have done their DD to the fullest or I will be jumping ship and looking for the
SS Caigakess!